LGL PARTNERS, LLC SAB Biotherapeutics, Inc. Transaction History

LGL PARTNERS, LLC portfolio value:

$16,000
portfolio value

LGL PARTNERS, LLC quarter portfolio value change:

-51.66%
quarter

SAB Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -17K $0.7 23K
Q2 2022 share Increase 0.00% 23K shares 33K $1.45 23K